N0436 (Alliance): A Phase II Trial of Irinotecan With Cetuximab in Patients With Metastatic Breast Cancer Previously Exposed to Anthracycline and/or Taxane-Containing Therapy
Clinical Breast Cancer - United States
doi 10.1016/j.clbc.2015.08.002
Full Text
Open PDFAbstract
Available in full text
Date
February 1, 2016
Authors
Publisher
Elsevier BV